[1] Goldstein LJ, Galski H, Fojo A, Willingham M, Lai A, Gazdar A, Driker R, Green A, Crist W, Brodeur GM, Lieber M, Cossman J, Gottesman MM, Pstan I. J Natl Cancer Inst, 1989, 81: 116. [2] Sanfilippo O, Ronchi E. DeMarco C, Difrozo G, Silvestrini R. Eur J Cancer, 1991, 27: 155. [3] Roninson IB. Biochem Pharmacol, 1992, 43: 95. [4] Kartner N, Riordan JR, Ling V. Scince (Washington), 1983, 211: 1285. [5] Endicott JA, Ling V. Annu Rev Biochem, 1989, 58: 137. [6] Tsuruo T, Lida K, Tsukagoshi S, Sakurai Y. Cancer Res, 1982, 42: 4730. [7] Inaba M, Fujikara R, Tsukagoshi S, Sukurai Y. Biochem Pharmacol, 1981, 30: 2191. [8] Twentyman PR, Fox NE, White DJ G. Br J Cancer, 1987, 56: 55. [9] Ma GX, Xu GJ, Xu LS. Acta Pharm Sin, 1994, 29: 763. [10] Ma GX, Xu GJ, Xu LS. Acta Pharm Sin, 1996, 31: 222. [11] Ma GX, Xu GJ, Xu LS. J China Pharm Univ, 1994, 25: 188. [12] Choi K, Frommel TO, Stern RK, Perez CF, Kriegler M, Tsuruo T, Roninson IB. Proc Natl Acad Sci USA, 1991, 88: 7386. [13] Egorin MJ, Hildebrand RC, Cimmino EF, Bachur NR. Cancer Res, 1974, 40: 2243. [14] Hamilton MA, Russo RC, Thurston RV. Envi ron Sci Tech, 1978, 11: 714. [15] Pettit GR, Sing SB. Can J Chem, 1987, 65: 2390. [16] Snyder JA, McIntosh RJ. NN Rev Biochem, 1976, 45: 699. [17] Hamel E. Pharmacol Ther, 1993, 55: 31. [18] Hamel E, Lin CM. Biochem Pharmacol, 1984, 32: 3864. [19] Betra J K, J urd L, Hamel E. Mol Pharmacol, 1984, 32: 3864. [20] McGown AT, Fox BW. Cancer Chemother Pharmacol, 1990, 26: 79. |